ArticleAnnals of translational medicine2023

Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentary.

Anand RottePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.